Appendix B: AIMS

The Abnormal Involuntary Movement Scale (AIMS) is an assessment tool used to document presence of tardive dyskinesia (TD), as well as to follow progression or remission of TD over time (Figure B1). TD can develop within three months of initial treatment with psychotropic medication; the AIMS is usually administered two to three times per year. There are different formats of the instrument (including fillable online), some with ranking by numbers and some with terms, such as mild, moderate, or severe. The scale is generally 12 questions with rating 0 (none) to 4 (severe). The items may be addressed by interview or observation. The client is observed standing, walking, and sitting. The presence of dentures is noted. The client is asked to extend the arms, move the legs and feet, open the mouth, and move the tongue while the examiner observes for abnormal movements, contractions, and grimaces. Lower scores in fewer categories are interpreted as requiring close monitoring, while higher scores in more categories indicate presence of TD. There are FDA-approved drugs to help stop the progression of TD.